Biovista
PrivateLast Round
Grant
Mar 6, 2012
Total Funding Raised
$500,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biovista is a biotechnology company that has developed an artificial intelligence-based platform intended to deliver custom drug repositioning, drug de-risking, and clinical hold services for the biopharma industry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Biotechnology, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS, Government Contracts, Data as a Service, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biovista Comparables
Compare Biovista with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delta4 | 90% | |
| Purposeful | 84% | |
| Healx | 80% | |
Biovista Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 6, 2012 | ||||
| Grant | May 5, 2011 |
Key People
Founding team and executive leadership
Biovista Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Solve ME/CFS Initiative | Grant |
| European Union Seventh Framework Programme | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors increased 123% MoM, reaching 4.8K.
- Feb 21, 2025
Grew 31% QoQ from 16 to 21 employees.
Biovista Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biovista's valuation, stock price, and market status.